Bruce Given
Arrowhead Pharmaceuticals, Inc.
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Bruce Given as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 19:34 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT02065336 · A Multicenter Study to Determine the Depth and Duration of Hepatitis B Surface Antigen (HBsAg) Reduction After Single or Multiple Doses of ARC-520, in Combination With Entecavir in Patients With Chronic Hepatitis B Virus (HBV) InfectionArrowhead Pharmaceuticals · terminated · Hepatitis B, Chronic · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-11 19:34 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 19:34 UTC. The ranking covers the 200 most relevant of 65 PubMed records, and a shared surname and initials can bring in a namesake. All 65 on PubMed
- RNAi-based treatment of chronically infected patients and chimpanzees reveals that integrated hepatitis B virus DNA is a source of HBsAg.Sci Transl Med · 2017432 citationsRCR 14.6
- 365 citationsRCR 31.6
- Effect of a cognitive behavioral intervention on reducing symptom severity during chemotherapy.J Clin Oncol · 2004141 citationsRCR 4.6
- Primary care clinicians treat patients with medically unexplained symptoms: a randomized controlled trial.J Gen Intern Med · 2006130 citationsRCR 4.8
- RNA Interference Therapy With ARC-520 Results in Prolonged Hepatitis B Surface Antigen Response in Patients With Chronic Hepatitis B Infection.Hepatology · 2020119 citationsRCR 5.5
- Pain and fatigue management: results of a nursing randomized clinical trial.Oncol Nurs Forum · 2002116 citationsRCR 3.9
- RNA interference targeting ANGPTL3 for triglyceride and cholesterol lowering: phase 1 basket trial cohorts.Nat Med · 202396 citationsRCR 8.4
- 95 citationsRCR 3.3
- Taking CHARGE: A self-management program for women following breast cancer treatment.Psychooncology · 200594 citationsRCR 2.8
- Fazirsiran for Liver Disease Associated with Alpha1-Antitrypsin Deficiency.N Engl J Med · 202294 citationsRCR 6.7